These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33664816)

  • 21. Comprehensively investigating the expression levels and the prognostic role of transforming growth factor beta-induced (TGFBI) in glioblastoma multiforme.
    Yin J; Liu JS; Feng M; Li JM; Lu S; Yang M; Cao BR; Lang JY; Zhu XD
    Transl Cancer Res; 2020 Oct; 9(10):6487-6504. PubMed ID: 35117257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression and Prognostic Value of ARID5A and its Correlation With Tumor-Infiltrating Immune Cells in Glioma.
    Zhou Q; Zhou J; Fan J
    Front Oncol; 2021; 11():638803. PubMed ID: 34094918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integrative Analysis Identifies TCIRG1 as a Potential Prognostic and Immunotherapy-Relevant Biomarker Associated with Malignant Cell Migration in Clear Cell Renal Cell Carcinoma.
    Xu C; Jia B; Yang Z; Han Z; Wang Z; Liu W; Cao Y; Chen Y; Gu J; Zhang Y
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230507
    [No Abstract]   [Full Text] [Related]  

  • 24. Development of an Immune-Related Prognostic Index Associated With Glioblastoma.
    Jiang Z; Shi Y; Zhao W; Zhang Y; Xie Y; Zhang B; Tan G; Wang Z
    Front Neurol; 2021; 12():610797. PubMed ID: 34093386
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular and clinical characterization of CD163 expression via large-scale analysis in glioma.
    Liu S; Zhang C; Maimela NR; Yang L; Zhang Z; Ping Y; Huang L; Zhang Y
    Oncoimmunology; 2019; 8(7):1601478. PubMed ID: 31143523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.
    Pangeni RP; Zhang Z; Alvarez AA; Wan X; Sastry N; Lu S; Shi T; Huang T; Lei CX; James CD; Kessler JA; Brennan CW; Nakano I; Lu X; Hu B; Zhang W; Cheng SY
    Epigenetics; 2018; 13(4):432-448. PubMed ID: 29927689
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of oncostatin M receptor regulates local immune response in glioblastoma.
    Guo Q; Guan GF; Cao JY; Zou CY; Zhu C; Cheng W; Xu XY; Lin ZG; Cheng P; Wu AH
    J Cell Physiol; 2019 Sep; 234(9):15496-15509. PubMed ID: 30693511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of a five-gene signature deriving from the vacuolar ATPase (V-ATPase) sub-classifies gliomas and decides prognoses and immune microenvironment alterations.
    Qi C; Lei L; Hu J; Wang G; Liu J; Ou S
    Cell Cycle; 2022 Jun; 21(12):1294-1315. PubMed ID: 35266851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The expression of Hexokinase 2 and its hub genes are correlated with the prognosis in glioma.
    Huang Y; Ouyang F; Yang F; Zhang N; Zhao W; Xu H; Yang X
    BMC Cancer; 2022 Aug; 22(1):900. PubMed ID: 35982398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrin Beta 5 Is a Prognostic Biomarker and Potential Therapeutic Target in Glioblastoma.
    Zhang LY; Guo Q; Guan GF; Cheng W; Cheng P; Wu AH
    Front Oncol; 2019; 9():904. PubMed ID: 31616629
    [No Abstract]   [Full Text] [Related]  

  • 31. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data.
    Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C
    Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the cancer genome atlas (TCGA) database identifies an inverse relationship between interleukin-13 receptor α1 and α2 gene expression and poor prognosis and drug resistance in subjects with glioblastoma multiforme.
    Han J; Puri RK
    J Neurooncol; 2018 Feb; 136(3):463-474. PubMed ID: 29168083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of aberrantly methylated differentially expressed genes in glioblastoma multiforme and their association with patient survival.
    Zhang M; Lv X; Jiang Y; Li G; Qiao Q
    Exp Ther Med; 2019 Sep; 18(3):2140-2152. PubMed ID: 31452706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and prognostic value of long non-coding RNA H19 in glioma via integrated bioinformatics analyses.
    Xiao Y; Zhu Z; Li J; Yao J; Jiang H; Ran R; Li X; Li Z
    Aging (Albany NY); 2020 Feb; 12(4):3407-3430. PubMed ID: 32081833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comprehensive Analysis of Prognostic Value and Immune Infiltration of IGFBP Family Members in Glioblastoma.
    Zhong Z; Xu X; Han S; Shao Y; Yi Y
    J Healthc Eng; 2022; 2022():2929695. PubMed ID: 35832140
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
    Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
    J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Whole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.
    Bao ZS; Zhang CB; Wang HJ; Yan W; Liu YW; Li MY; Zhang W
    CNS Neurosci Ther; 2013 Sep; 19(9):714-20. PubMed ID: 23663361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of immunologic subtype and prognosis of GBM based on TNFSF14 and immune checkpoint gene expression profiling.
    Long S; Li M; Liu J; Yang Y; Li G
    Aging (Albany NY); 2020 Apr; 12(8):7112-7128. PubMed ID: 32310827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dissecting Prognosis Modules and Biomarkers in Glioblastoma Based on Weighted Gene Co-Expression Network Analysis.
    Cao F; Fan Y; Yu Y; Yang G; Zhong H
    Cancer Manag Res; 2021; 13():5477-5489. PubMed ID: 34267555
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.
    Cheng W; Ren X; Zhang C; Cai J; Liu Y; Han S; Wu A
    Neurology; 2016 Jun; 86(24):2226-34. PubMed ID: 27225222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.